We used mass spectrometry-based proteomics data for BRAF-mutant melanoma lines in the Cancer Cell Line Encyclopedia (CCLE)43 to evaluate possible correlations between the expression of each epigenetic target and the relative expression of Ngfr and Axl. The gene discussed is AXL; the disease is melanoma.